资讯|论坛|病例

搜索

首页 医学论坛 专业文章 医学进展 签约作者 病例中心 快问诊所 爱医培训 医学考试 在线题库 医学会议

您所在的位置:首页 > 肾内科诊疗指南 > 2006CARI指南—膜性肾病:环孢素治疗的作用

2006CARI指南—膜性肾病:环孢素治疗的作用

2014-05-27 15:46 阅读:1624 来源:爱爱医 责任编辑:张子玲
[导读] Idiopathic MGN is the most common form of nephrotic syndrome in **s. Althoughmany patients have a benign course or undergo spontaneous complete or partialremission

    《2006CARI指南—膜性肾病:环孢素治疗的作用》内容简介:

    Idiopathic MGN is the most common form of nephrotic syndrome in **s. Althoughmany patients have a benign course or undergo spontaneous complete or partialremission, 30–40% of patients progress toward nd-stage kidney disease (ESKD)within 5–15 years (Schieppati et al 1993; Geddes et al 2000), sometimes months oryears after the onset of nephrotic syndrome and a substantial percentage of patientsnever progress to kidney failure. To avoid possibly unnecessary treatments, mostclinical studies have focused on individuals who are thought to be at greater risk forprogressive disease. The objective of this guideline is to evaluate the availableclinical evidence pertaining to the impact of cyclosporine on renal functional declinein MGN with poor prognostic features, such as heavy proteinuria (> 3 g/24 h),impaired renal function at presentation, deteriorating renal function and/orreducedresponse to therapy.

    《2006CARI指南—膜性肾病:环孢素治疗的作用》内容预览:

  
  Cattran et al (1995) randomised 51 patients with biopsy-proven idiopathicMGN and nephrotic-range proteinuria to 26 weeks of cyclosporine treatmentplus low-dose prednisone to placebo plus prednisone. Seventy five per cent ofthe treatment group vs. 22% of the control group (P < 0.001) had a partial orcomplete remission of their proteinuria by 26 weeks. Relapse occurred in 43%(N = 9) of the cyclosporine remission group and 40% (n = 2) of the placebogroup by week 52. Form this time until the end of the study at 78 weeks, thefraction of the total population in remission remained unchanged (cyclosporine39%, placebo 13%, P = 0.007)。 Renal insufficiency, defined as doubling ofbaseline creatinine, was seen in 2 patients in each group.

    In a recent meta-**ysis of placebo-controlled trials of cyclosporine/prednisolone,involving 104 randomised patients, no clinically relevant beneficial effect wasobserved (Schieppati et al 2004)。 Nonetheless, partial remissions were morefrequent in cyclosporine-treated patients than in those treated with alkylating agents(partial remission RR 1.68, 95%CI: 1.06–2.65, P = 0.03).

    点击下载***:《2006CARI指南—膜性肾病:环孢素治疗的作用》


分享到:
  版权声明:

  本站所注明来源为"爱爱医"的文章,版权归作者与本站共同所有,非经授权不得转载。

  本站所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们

  联系zlzs@120.net,我们将立即进行删除处理

意见反馈 关于我们 隐私保护 版权声明 友情链接 联系我们

Copyright 2002-2024 Iiyi.Com All Rights Reserved